Memantine (Axura)
Substance developed by the Merz research organization used to treat dementia and Alzheimer's Disease.
memantine.com - Brief Profile
Memantine is the first and only representative of a new class of Alzheimer drugs ... Memantine has been developed by Merz Pharmaceuticals and is approved in Europe ...
Merz Pharma
Merz - We Care. Research for your health. ... Memantine / Namenda. Please ask us how to obtain Memantine or Namenda. German Websites ...
Memantine - Wikipedia, the free encyclopedia
Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by ... Memantine is also being tested for opioid dependence, systemic lupus ...
Alzheimer's Substance Memantine strenghtens worldwide market position ...
Just three years after securing its approval in Europe and the United States, ... Memantine, an NMDA (N-methyl-D-aspartate) antagonist developed by Merz, is the ...
Merz Group: Information from Answers.com
Company Perspectives At Merz, our mission is to assume responsibility for ... Merz's flagship molecule is Memantine, an active ingredient used to treat ...
MERZ + CO./FOREST LABS SIGN PACT FOR MEMANTINE DEVELOPMENT.
Neurobiological Technologies, Inc. (NTI*) (OTC-BB:NTII), Richmond,Calif. ... Merz has completed three separate Phase III clinical trials of Memantine for ...
NTI " Products
In Europe, memantine has been marketed by Merz & Co. for a number of indications ... Alzheimer's disease, memantine is now being sold by Merz's European marketing ...
Dementia Autism Alzheimer's disease Memantine neuropathic pain AIDS ...
In June 2000, Memantine was explored for use in the United States for the ... In May 2002, Merz announced that Memantine (Ebixa") was approved by the ...
Memantine and Antipsychotics Use - Full Text View - ClinicalTrials.gov
Verified by Merz Pharmaceuticals GmbH, September 2008 ... Intake of any medication that is contra-indicated in combination with memantine. ...
|
The EU